Phase I
Rexahn begins solid tumor trial . . . read more

Phase III
Catalyst, BioMarin post positive Firdapse results . . . read more

Repros' Androxal in head-to-head testosterone trial . . . read more

Phase IV
Exparel performs strongly against IV PCA opioid . . . read more

Filings
EMA accepts HCV MAA from BMS . . . read more

NPS bla accepted for hypoparathyroidism . . . read more

Approvals
Merck HIV treatment approved in oral suspension . . . read more